MedPath

Exercise Training and Glucose Metabolism in Aging

Not Applicable
Completed
Conditions
Type 2 Diabetes Mellitus
Impaired Glucose Tolerance (Prediabetes)
Interventions
Behavioral: Aerobic exercise training
Behavioral: Detraining (cessation of exercise)
Registration Number
NCT00701051
Lead Sponsor
US Department of Veterans Affairs
Brief Summary

Diabetes and its associated complications affect more than 20 million Americans, and the prevalence of type 2 diabetes and impaired glucose tolerance rises dramatically with age such that 40% of Americans over age 60 are affected. In older adults, glucose metabolism may be affected by reduced skeletal muscle capillary supply, which limits insulin, glucose, and oxygen delivery to skeletal muscle. Reduced capillary supply to skeletal muscle is found in older individuals with impaired glucose tolerance and we hypothesize that this is due to reduced vascular growth factor expression, and chronic inflammation. Further, we hypothesize that reversal of a sedentary lifestyle through aerobic exercise training will increase insulin signaling and vascular growth factor expression, as well as decrease inflammation, to increase capillary supply to skeletal muscle, which contributes to improved glucose metabolism in older adults. This study will: 1) Determine the mechanisms underlying reduced skeletal muscle capillarization in older adults with impaired glucose tolerance; and 2) Determine the effect of aerobic exercise training-induced increases in skeletal muscle capillarization on glucose metabolism in older adults.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Age 50-75 years
  • Non-smoker >2 years
  • Body mass index = 18-35 kg/m2
Exclusion Criteria
  • History of CAD or cerebrovascular disease that would preclude exercise
  • Implantable defibrillator
  • Active cancer
  • Chronic pulmonary, thyroid, renal, liver, or hematological disease
  • HIV positive or prone to malnutrition
  • Sickle cell anemia
  • Type 1 diabetes, or currently on medication to treat type 2 diabetes
  • Poorly-controlled type 2 diabetes
  • Poorly-controlled hypertension
  • Taking medications including: beta-blockers, oral steroids, warfarin, certain statins, hormone replacement therapy (HRT), oral contraceptives (OCP), thiazolidinediones (TZD), or chronic steroids or nonsteroidal analgesics (NSAIDS) that may not be safely discontinued temporarily for specific procedures (i.e. for 72 hours prior)
  • Allergic to lidocaine or heparin
  • Recent weight change (>5kg in 3 months)
  • Currently pregnant or nursing
  • Physical impairment limiting exercise
  • Dementia or unstable clinical depression

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm 1Aerobic exercise trainingOlder adults, normal glucose tolerance
Arm 1Detraining (cessation of exercise)Older adults, normal glucose tolerance
Arm 2Aerobic exercise trainingOlder adults, impaired glucose tolerance
Arm 2Detraining (cessation of exercise)Older adults, impaired glucose tolerance
Primary Outcome Measures
NameTimeMethod
Baseline Glucose Utilizationbaseline

Insulin-stimulated glucose uptake

Glucose Utilization (Pre/Post Intervention)baseline, 24 weeks, 26 weeks

Insulin-stimulated glucose uptake

Baseline Skeletal Muscle Capillarizationbaseline
Skeletal Muscle Capillarization (Pre/Post Intervention)baseline, 24 weeks, 26 weeks
Secondary Outcome Measures
NameTimeMethod
Baseline 2-hour Postprandial Glucosebaseline
Baseline Cardiorespiratory Fitnessbaseline

maximal oxygen consumption

Cardiorespiratory Fitnessbaseline, 24 weeks, 26 weeks

Maximal oxygen consumption

Body Composition (%Fat)baseline, 24 weeks
2-hr Post-prandial Plasma Glucose Levelbaseline, 24 weeks, 26 weeks

Trial Locations

Locations (1)

VA Maryland Health Care System, Baltimore

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath